January 22, 2007 Role of Litigation in Defining Drug Risks_JAMA / BMJBelow are excerpts from two timely articles that offer persuasive arguments backed by evidence demonstrating that litigation Read More Role of Litigation in Defining Drug Risks_JAMA / BMJ
January 6, 2007 NEJM- Caught Covering Up for National Kidney Foundation–an indudstry front group The latest example of corruption at the NEJM was reported by The Wall StreetJournal (below). The NEJM Read More NEJM- Caught Covering Up for National Kidney Foundation–an indudstry front group
December 4, 2006 IRB Forum Not Inclined to Discuss the Most Serious Issue of AllI posted to the IRB Forum (a chatroom) the AHRP Infomail reporting about the Harvard study of Read More IRB Forum Not Inclined to Discuss the Most Serious Issue of All
November 29, 2006 Hospital IRBs are “On the Take”–Tainted by Conflicts ofInterest_NEJMThose who approve research protocols, ethics committees–called, institutional review boards, IRB–are riddled with conflicts of interest. In Read More Hospital IRBs are “On the Take”–Tainted by Conflicts ofInterest_NEJM
November 23, 2006 Dangerous Deception: Hiding the Evidence of Adverse Drug Effects_NEJMThe drug industry's undue influence–on the FDA and its advisory committees that are made up mostly of Read More Dangerous Deception: Hiding the Evidence of Adverse Drug Effects_NEJM
November 4, 2006 Potent Narcotic ‘Lollipop’ Becomes Best Seller_WSJA prescription drug’s success is measured by the size of the population in which it is used. Read More Potent Narcotic ‘Lollipop’ Becomes Best Seller_WSJ
October 31, 2006 NIMH Chief Child/Adoles Research Blows Wind out TeenScreen Sails_ Los Angeles TimesThe Los Angeles Times reports (below) about the latest study in "a welter of efforts to identify Read More NIMH Chief Child/Adoles Research Blows Wind out TeenScreen Sails_ Los Angeles Times
October 26, 2006 "The scariest thing is that nobody knows" risks of depression drugs for children“The scariest thing is that nobody knows” risks of depression drugs for children Mon, 10 May 2004 Read More "The scariest thing is that nobody knows" risks of depression drugs for children
October 26, 2006 FDA MedWatch data show olanzapine (Zyprexa) -diabetes riskJuly 12, 2002 Babies Exposed to Toxic Vaccines FYI Several recent articles focus on unsafe vaccines: ABC Read More FDA MedWatch data show olanzapine (Zyprexa) -diabetes risk
October 26, 2006 What’s New? – Alliance for Human Research ProtectionTo view AHRP news and infomails from 2006, please visit our new site. Infomails Subscribe to AHRP’s Read More What’s New? – Alliance for Human Research Protection
October 26, 2006 Featured NewsAHRP Speaks Out AHRP Press Briefing 9/14/04: Antidepressants & suicide-related risks for children Open Letter to NIMH Read More Featured News
October 26, 2006 ArticleFrom: “VERACARE” To: “Dr. Bart Campbell” Subject: RE: AHRP Response to criticism re: fatal ARDS lung experiment Read More Article
October 26, 2006 FDA: Regulatory Protections for Children. Comments by Sharav, Noble, & Fishman for AHRPFDA: regulatory protections for children. Comments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and Read More FDA: Regulatory Protections for Children. Comments by Sharav, Noble, & Fishman for AHRP
October 26, 2006 Public Comments Dr. William J. Bicknell Prof. Int’l Health, Boston UPublic Comments: Dr. William J. Bicknell, Professor of International Health, Boston University Dear Dr. Ball: I am Read More Public Comments Dr. William J. Bicknell Prof. Int’l Health, Boston U